We therefore sought to elucidate this relationship by examining the association between statin sensitivity and YAP/TAZ activity in six NSCLC cell lines exhibiting varying epithelial-mesenchymal phenotypes. This evidence concerns the gene YAP1 and non-small cell lung carcinoma.